Trials / Unknown
UnknownNCT00959153
Extracorporeal Shock Wave Lithotriptor Indicated for Fragmenting Urinary Stones in the Kidney
Extracorporeal Shock Wave Lithotriptor Indicated for Fragmenting Urinary Stones in the Kidney (Renal Pelvis)
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Advance Shockwave Technology GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A total of 20 subjects presenting with urinary stone(s) in the kidney or ureter will be treated with an extracorporeal shockwave lithotripsy device to fragment the stones. Subjects will be followed for 14 days. If at the 14 day follow-up visit the subject continues to present with a stone size 4 mm or greater will have an option of retreatment or other intervention. If the subject consents to be retreated at this time, this subject will be followed up for another 14 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LithoSpace Extracorporeal Shockwave Lithotripter | Shockwave therapy to break up kidney stones |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2011-08-01
- Completion
- 2011-08-01
- First posted
- 2009-08-14
- Last updated
- 2011-06-01
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00959153. Inclusion in this directory is not an endorsement.